Analysis of Immunological Nonresponsiveness to the 19-Kilodalton Fragment of Merozoite Surface Protein 1 ofPlasmodium yoelii: Rescue by Chemical Conjugation to Diphtheria Toxoid (DT) and Enhancement of Immunogenicity by Prior DT Vaccination
Open Access
- 1 October 2003
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 71 (10) , 5700-5713
- https://doi.org/10.1128/iai.71.10.5700-5713.2003
Abstract
ThePlasmodiummerozoite surface protein 1 (MSP1) is a leading vaccine candidate for protecting against the blood stage of malaria. Previous studies have shown that the 19-kDa carboxyl terminus of this protein is able to induce protective immunity in some monkey and mouse strains. We show that immunization with the recombinantPlasmodium yoelii19-kDa fragment of MSP1 (MSP119) expressed inSaccharomyces cerevisiae(yMSP119) can induce protective antibodies in several inbred mouse strains and one outbred mouse strain. However, mice expressing theH-2smajor histocompatibility complex haplotype are unable to generate yMSP119-specific antibodies. While synthetic peptides derived from MSP119are immunogenic in B10.S mice, they cannot function as helper epitopes, and immunization with yMSP119does not induce T cells that recognize the recombinant protein or synthetic peptides corresponding to its sequence. Nonresponsiveness could be overcome by using chemical linkers to conjugate yMSP119to diphtheria toxoid (DT), resulting in immunogens capable of inducing protective yMSP119-specific antibodies in both MSP119-responsive and otherwise nonresponsive mouse strains. The ability of sera from mice immunized with the conjugate to inhibit binding of a protective monoclonal antibody (MAb 302) to yMSP119correlated strongly with a delay in the prepatent period. Chemical conjugation of yMSP119to DT may be a preferred method to enhance immunogenicity, as carrier priming experiments demonstrated that an existing immune response to DT enhanced a subsequent antibody response to yMSP119after vaccination with yMSP119-DT. These results have important implications for the development of a malaria vaccine to protect a population with diverse HLAs.Keywords
This publication has 47 references indexed in Scilit:
- Nature and Specificity of the Required Protective Immune Response That Develops Postchallenge in Mice Vaccinated with the 19-Kilodalton Fragment ofPlasmodium yoeliiMerozoite Surface Protein 1Infection and Immunity, 2002
- Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-119) and T helper epitopes of tetanus toxoidVaccine, 1999
- Intranasal immunization with yeast‐expressed 19 kD carboxyl‐terminal fragment of Plasmodium yoelii merozoite surface protein‐1 (yMSP119) induces protective immunity to blood stage malaria infection in miceParasite Immunology, 1998
- Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP119) and their role in immunity to malariaParasite Immunology, 1998
- Antibody and clinical responses in volunteers to immunization with malaria peptide–diphtheria toxoid conjugatesClinical and Experimental Immunology, 1995
- A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.The Journal of Experimental Medicine, 1990
- EFFECT OF PRIMING WITH CARRIER ON RESPONSE TO CONJUGATE VACCINEThe Lancet, 1989
- Construction of Synthetic Immunogen: Use of New T-Helper Epitope on Malaria Circumsporozoite ProteinScience, 1987
- Carrier-priming leads to hapten-specific suppressionNature, 1980
- The Thymus and the Precursors of Antigen Reactive CellsNature, 1967